Related Experiment Video
Updated: Aug 15, 2026

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
Fatal myoglobinuric renal failure in a patient with tardive dyskinesia
Abstract:
A patient with severe tardive dyskinesia developed fatal myoglobinuric renal failure. Myoglobinuria has followed other forms of extreme muscular exertion, but has not been previously reported consequent to tardive dyskinesia. Antipsychotic medication should be used to treat severe tardive dyskinesia when alternative forms of therapy are ineffective and discontinuing therapy might otherwise lead to an exacerbation of symptoms with life-threatening complications.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Drug Toxicity: Dose-Dependent Reactions
Tetanus
Huntington Disease l: Introduction
Alterations in Muscle Tone lll

